about
Chromosome 11q13 abnormalities in human breast cancerThe fms gene and the CSF-1 receptorGuido Pontecorvo and his contribution to geneticsControl of ras activation.The bcr-abl gene in chronic myelogenous leukaemia.Growth factors as novel therapeutic targets in neoplastic disease.S phase damage sensing checkpoints in mammalian cells.Pain and symptom control in paediatric palliative care.Immunolocalization of steroid hormone receptors in normal and tumour cells: mechanisms of their cellular traffic.Paraneoplastic syndromes.Cell biology of precancer.Molecular precursor lesions in oesophageal cancer.Skin precancer.Molecular alterations in bladder cancer.Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.Precancer of the prostate.The dynamics of early intestinal tumour proliferation: to be or not to be.Precancer of the human cervix.Personality, coping style, emotion and cancer: towards an integrative model.CDKN2 mutations in melanoma.The role of ICAM expression in immunity and disease.The cognitive and psychomotor effects of opioid drugs in cancer pain management.Germline mutations in the TP53 gene.Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals.Functional evidence for human tumour suppressor genes: chromosome and molecular genetic studies.Control of the ERK MAP kinase cascade by Ras and Raf.Role of the WT1 gene in Wilms' tumour.Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.T cell recognition of Epstein-Barr virus associated lymphomas.Progression from steroid sensitive to insensitive state in breast tumours.Retinoic acid receptors in normal growth and development.Retinoic acid receptor alpha in acute promyelocytic leukaemia.Mechanistic interrelationships between two superfamilies: the steroid/retinoid receptors and transforming growth factor-beta.Peroxisome proliferators: a model for receptor mediated carcinogenesis.Adenovirus E1A targets key regulators of cell proliferation.Cytotoxic T lymphocytes and immune surveillance.Thyroid hormone receptors and their role in development.The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?Interactions between p21ras proteins and their GTPase activating proteins.The role of surface HLA-A,B,C molecules in tumour immunity.
P1433
Q28243938-53BE463F-DF05-4D84-8122-8A942397687CQ28287776-DB90B7F2-0459-4899-B5B7-1FF6BB78E4EBQ28289612-155B1F14-9438-4F09-ADA1-0DBEB2047756Q30192746-58B41905-89FF-438A-9E0F-2201BA0F96EDQ30195534-328F4D86-3CE2-45EF-8482-8220AF6D55F6Q30403594-CC84DC56-8E70-4A77-82B9-BDA79098942BQ30471146-CB426096-ED46-4664-B7D6-676B6E4EB18CQ30537913-3A011764-550F-42D2-B772-D465EC000256Q30817711-98320794-6056-4BD8-AD4D-85B249C96B4AQ33495233-41419D33-7B26-4CE1-8464-00588FF9D799Q33734011-07A1D9A1-3A6B-4A52-B82F-671F72C6635FQ33734022-05E71638-B8A3-47CD-9EAD-2333B0CA20CCQ33734028-0D9CEF7F-F3F0-4A5A-80EB-5728C6153581Q33734033-C8728F80-1FCC-4930-B174-335CA54A36B9Q33734039-7B13C9D5-205E-4B12-B9DB-B8BA57BEF00CQ33734044-E28DBDA7-80D7-473F-98F2-532B6FE3B79BQ33734048-D4E13E75-2BA6-4D4C-B7D0-6383CAA76F20Q33734052-7216AFC6-BE0B-41DB-8801-D4E34C2439C8Q34049597-D7740FFE-F911-4831-8D37-062516BD9448Q34063159-4A0E1FA3-F046-409B-9120-89ACFC038219Q34294921-56EE9A15-74A4-4DE8-B0F6-94F3CF08A462Q34371879-9124980F-0617-4BF1-86FB-15D3831585E8Q34389730-3D6EE267-256B-4D1B-BA28-D04C862C2716Q34406617-EA567863-7C44-450C-B222-418EAA3310D9Q34538787-D15EE44E-1A79-4407-9164-2B3108AE00CEQ34662994-93808112-494A-4FED-9A37-465269135AB2Q35230889-C8287091-ADC5-455A-A5E5-A323D0946F87Q35230893-C1212F3A-FFAC-4E56-8A6E-DBBF2077A67EQ35234954-6E58C0A4-2B64-4354-A77D-1B84A22B19FAQ35234957-89FE655F-6223-4D0C-8D13-BCB1A4CBCA9AQ35234961-813D9512-D8CB-43D9-B669-7335E7859945Q35234965-01878665-3FCA-43B6-95CE-0459EEA6C40FQ35234973-FE215CEE-3E29-418E-BFE5-048525BA633FQ35234980-B32334A1-0240-49B7-80F4-ACBE6C8CBE74Q35260997-3A8770F5-2B18-403A-8172-DB5860D82F8FQ35269198-8C1E7556-0486-440F-A9F7-3373398C3AA5Q35269217-830ED19B-9285-4886-A0A6-C217E5520F99Q35269231-EBD3F5B6-51C1-48B4-90FC-D77540F89E9FQ35347157-BBD60764-DE0A-45D7-BD56-F8FA77CCC287Q35475241-D077DA09-8411-4121-ADFE-7D88D90F563C
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Cancer surveys
@ast
Cancer surveys
@en
Cancer surveys
@es
Cancer surveys
@it
Cancer surveys
@nl
type
label
Cancer surveys
@ast
Cancer surveys
@en
Cancer surveys
@es
Cancer surveys
@it
Cancer surveys
@nl
altLabel
Cancer Surv
@en
Cancer Surv.
@en
prefLabel
Cancer surveys
@ast
Cancer surveys
@en
Cancer surveys
@es
Cancer surveys
@it
Cancer surveys
@nl
P1055
P1156
P1277
P1476
Cancer surveys
@en